NUVECTIS PHARMA INC's ticker is and the CUSIP is 67080T108. A total of 34 filers reported holding NUVECTIS PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STRS OHIO | 3,900 | $50 | 0.00% |
| CITIGROUP INC | 5 | $65 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 19,920 | $256,769 | 0.00% |
| MORGAN STANLEY | 3,479 | $44,845 | 0.00% |
| AMALGAMATED BANK | 1,039 | $13 | 0.00% |
| BlackRock Inc. | 359,447 | $4,633,272 | 0.00% |
| Nuveen Asset Management, LLC | 10,669 | $137,523 | 0.00% |
| Bank of New York Mellon Corp | 19,150 | $246,844 | 0.00% |
| JPMORGAN CHASE & CO | 4,902 | $63,187 | 0.00% |
| BARCLAYS PLC | 1,389 | $18 | 0.00% |
| ROYAL BANK OF CANADA | 1,088 | $14,000 | 0.00% |
| VANGUARD GROUP INC | 291,134 | $3,752,717 | 0.00% |
| Ameritas Investment Partners, Inc. | 566 | $7,296 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 1,641 | $21,152 | 0.00% |
This page lists NUVECTIS PHARMA INC's shareholders in Q3 2023. To view NUVECTIS PHARMA INC's shareholder history, click here.